Table 7.
Incidence of IORN of the upper and lower jaw in the literature
| Author group | Year of publication | Incidence | Remarks |
|---|---|---|---|
| Ben-David et al. [13] (n = 176) |
2007 |
0 |
Multiple tumour localizations |
| Primary treatment (no surgery) | |||
| IMRT | |||
| 108/176 radiochemotherapy | |||
| Berger et al. [14] |
2010 |
1-5% |
Literature survey |
| Crombie et al. [15] (n = 54) |
2012 |
36% |
53/54 radiochemotherapy |
| Gomez et al. [16] (n = 168) |
2011 |
1.2% |
Multiple tumour localizations |
| IMRT | |||
| Gomez et al. [29] (n = 35) |
2009 |
5% |
IMRT |
| Jerecek-Fosså et al. [17] |
2002 |
0.4-56% |
Literature survey |
| Jham et al. [7] (n = 207) |
2008 |
5.5% |
Head and neck cancer |
| Katsura et al. [18] (n = 39) |
2008 |
15% |
|
| Lee et al. [19] (n = 189) |
2008 |
6.6% |
Oral cavity and oropharynx |
| Monnier et al. [20] (n = 73) |
2011 |
40% |
Oral cavity and oropharynx |
| Oh et al. [21] (n = 81) |
2004 |
4.9% |
|
| Reuther et al. [5] (n = 830) |
2003 |
8.2% |
Oral cavity and oropharynx |
| Stenson et al. [22] (n = 27) |
2010 |
18.4% |
Surgery, adjuvant radiochemotherapy |
| Storey et al. [23] (n = 83) |
2001 |
6% |
Malignant submandibular tumours |
| Studer et al. [24] (n = 304) |
2011 |
Grade 2 EORTC: 1.6% |
Oral cavity and oropharynx |
| Conventional dental care vs. risk-adapted dental care | |||
| IMRT | |||
| Thiel [25] |
1989 |
4-35% |
Literature survey |
| Thorn et al. [26] (n = 80) |
2000 |
74%/3 years |
Multiple tumour localizations |
| Tsai et al. [27] (n = 402) |
2013 |
7.5% |
Oropharyngeal cancer, median time to IORN 8 months |
| Turner et al. [28] (n = 333) | 1996 | 5.9% |